AFYS3G launches a new recapping solution to accelerate sample storage workflows: the Recapper for Screw Cap Tubes Sigma96. Designed to improve efficiency, the AFYS3G Recapper for Screw Cap Tubes can be used as a stand-alone instrument or be simply integrated into a fully automated laboratory environment. This makes the recapper ideal for high throughput workflows, to scale-up sample processing for (COVID-19) testing or research, and to relieve researchers from repetitive manual labor...
Scope Fluidics – a biotechnological company listed on NewConnect, developer of innovative medical diagnostics projects – has commenced prevalidation tests of the PCR|ONE SARS-CoV-2 panel on clinical samples. The tests will be conducted in a hospital laboratory, on swabs collected directly from patients. The aim of the initiated tests is to check the effectiveness of the developed panel, which has so far been validated in the course of internal tests....
Beckman Coulter, a clinical diagnostics leader, has announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The assay detects antibodies that recognize the receptor binding domain (RBD) of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells. The assay, which demonstrates 99.9% specificity and 98.3% sensitivity, is part of a suite of diagnostic solutions....
A BREAKTHROUGH test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx. The test, called MicrosensDx COVID-19, has been used successfully in large scale testing programs with BAE Systems in Cumbria over the last few months, where it has been deployed to test more than 8,000 people a week....
If you give money to medical or research charities, you probably don’t expect 20 per cent of your donation to be clawed back in VAT, however, because of confused guidance on applying zero-rate VAT relief, that’s exactly what often happens. Furthermore, now the temporary relief afforded by the Government’s decision to make all PPE VAT-free came to an end on 31st October, VAT will now be charged on PPE sold for charitably funded medical and veterinary use....
PerkinElmer, Inc. has announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer® New Coronavirus Nucleic Acid Detection Kit to increase the number of individuals who can be tested without increasing resources. This validation of batch testing using the industry’s most sensitive assay to date according to the FDA Reference Panel leverages its proven ability to detect low amounts of viral genetic material....
Porvair Sciences has introduced a new 2.2ml 96 deep well plate specifically designed to be fully compatible with the Thermo Scientific™ KingFisher™ range of nucleic acid purification systems. For many labs, up-front sample preparation and handling represents a major bottleneck in their research workflow, as it is largely done manually. Widely used for the nucleic acid purification step in SARS-CoV-2 testing, the KingFisher™ Flex instrument can process 96 samples per run when paired with 96 deep-well microplates....
Merck, a leading science and technology company, has announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Mammoth’s high-throughput systems will be compatible with both nasal swab and saliva samples and are targeting approximately 1,500 tests per 8-hour shift with minimal user interaction....
Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has completed the United States Food and Drug Administration (FDA) notification process for its CDC formulation Viral Transport Medium (VTM). Therefore, Teknova Viral Transport Medium is in compliance with the FDA’s COVID-19 Transport Media Policy, July 2020 guidelines. Teknova is now offering the validated Teknova Viral Transport Medium for commercial distribution.
UNION therapeutics A/S (UNION) announces expansion of the clinical pipeline with the addition of UNI91103 (intranasal niclosamide) to prevent COVID-19 and reduce the severity of the diseases among those already infected. Several high-risk patient groups do not respond well to vaccination suggesting a persistent need for alternative prophylactic measures. In response, UNION has expanded its clinical program for COVID-19 with a niclosamide based nasal spray...
EKF Diagnostics, the global in vitro diagnostics company, announces that it has launched a PrimeStore® MTM sample collection kit. This new kit enables convenient and safe collection, transportation and handling of pathogenic samples, including COVID-19 and influenza. Two kit configurations are now available: a postal sample kit ideal for home use and a multi-pack of sample kits suitable for on-site mass sampling....
PerkinElmer, Inc. has announced that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD). This test is currently under review by the U.S. FDA for Emergency Use Authorization (EUA). The multi-analyte panel enables labs to detect and differentiate between SARS-CoV-2, influenza A viruses, influenza B viruses and respiratory syncytial virus (RSV) in a single test...
In response to global demand for dependable technologies designed to optimize COVID-19 testing, Atik Cameras, specialist designer and manufacturer of advanced scientific imaging solutions, has developed the new VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments — the most commonly used systems for detection of the SARS-CoV-2 virus....
The medical IVD market is currently undergoing rapid change that is challenging instrument designers at many levels to meet new demands. It’s also a large, growing market and includes the development of instruments for key applications such as COVID-19 testing. Increased cost pressures for new (and existing) applications demands more efficient testing, maximising throughput, not only for sample and reagent usage, but also in reliability and speed....
New Range of CE Certified Face Visors and Type II Masks with Introductory 10% Savings. Alpha Laboratories now supplies personal protective equipment, including CE certified safety visors and Type II standard face masks which are suitable for use in a wide variety of healthcare roles and non-healthcare settings. Both our visors and masks are perfect for protecting the wearer from inward inhalation of aerosol droplets that may carry COVID-19 or other virus particles...
Evaxion Biotech A/S has received funding from the Danish Innovation Fund to further develop their AI platform RAVEN to rapidly respond against future corona virus pandemics - from initial discovery to first in human trials in as little as 13 weeks. During those 13 weeks SB3000 intends to develop and validate a tailored μLOT® continuous manufacturing process for the vaccine at commercial scale. Being modular and easily transportable the μLOT® enabled production units can be deployed to sites across the world....
AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of SARS-CoV-2 antibodies and antigens to aid development of new immunoassay diagnostic kits. While RT-PCR diagnostic kits has provided fast and sensitive COVID-19 case confirmation, the technique suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection....
World’s Simplest High Throughput RT-PCR Test for COVID-19 has the potential to increase testing capacity by millions per week. BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19....
Recognizing the tremendous pressure labs are experiencing to turn around COVID-19 test results, GoMeyra LIMS was specifically designed and developed as a solution to alleviate bottlenecks and increase efficiency challenges inherent in laboratory workflows. By bringing together the bioinformatic expertise of world-class scientists with enterprise-level software engineers, GoMeyra is an unparalleled digital solution for medical laboratories....
After encouraging results obtained under named patient use in severe cases of COVID-19, F4 Pharma is now preparing clinical trials in several European centers with its substance FX06. There is emerging evidence that severe COVID-19 affects all organs through a systemic inflammation of the inner layer of the small blood vessels leading to increased permeability of the capillaries, which can finally result in multi-organ failure and death...
Sonic Healthcare UK’s Group Medical Director, Dr Rachael Liebmann, and Ann Hannah, Rapid Response Laboratories and Histology Manager, have been recognised in the Queen’s Birthday Honours. Dr Liebmann has been awarded an OBE (Officer of the Most Excellent Order of the British Empire) in the Queen’s Birthday Honours in recognition of her services to pathology. Ann Hannah has been awarded a BEM (British Empire Medal) for her services to healthcare during the Covid-19 pandemic....
ILC Therapeutics, a Scottish biotech company, has announced that its unique synthetic Interferon called Alfacyte™ is fifteen to twenty times more effective at preventing the spread of SARS-CoV-2 (the virus which causes COVID-19) in cell culture than other commercially-available Interferons such as Interferon alpha 2 and Interferon beta 1a. COVID-19 tries to slow down the body’s innate Interferon response to viral infection and Alfacyte™ is designed to help accelerate this response and prevent disease progression....